Publisher
Springer International Publishing
Reference68 articles.
1. Addonizio, G., & Susman, V. L. (1987). ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. The Journal of Clinical Psychiatry, 48(3), 102–105.
2. Alfishawy, M., Bitar, Z., Elgazzar, A., et al. (2021). Neuroleptic malignant syndrome following COVID-19 vaccination. The American Journal of Emergency Medicine, 49, 408–409.
3. Ali, Z., Roque, A., & El-Mallakh, R. S. (2020). A unifying theory for the pathoetiologic mechanism of tardive dyskinesia. Medical Hypotheses, 140, 109682.
4. Barnes, T. R. (1989). A rating scale for drug-induced akathisia. The British Journal of Psychiatry, 154, 672–676.
5. Barrett, J. J., Sargent, L., Nawaz, H., et al. (2021). Antimuscarinic anticholinergic medications in Parkinson disease: To prescribe or deprescribe? Movement Disorders, 8(8), 1181–1188.